BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34580604)

  • 1. PP2 Ameliorates Renal Fibrosis by Regulating the NF-
    Wei J; Deng X; Li Y; Li R; Yang Z; Li X; Song S; Shi Y; Duan H; Wu H
    Oxid Med Cell Longev; 2021; 2021():7394344. PubMed ID: 34580604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDK5 promotes renal tubulointerstitial fibrosis in diabetic nephropathy via ERK1/2/PPARγ pathway.
    Bai X; Hou X; Tian J; Geng J; Li X
    Oncotarget; 2016 Jun; 7(24):36510-36528. PubMed ID: 27145370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
    Liu P; Li F; Qiu M; He L
    Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc Attenuates Tubulointerstitial Fibrosis in Diabetic Nephropathy Via Inhibition of HIF Through PI-3K Signaling.
    Zhang X; Liang D; Fan J; Lian X; Zhao Y; Wang X; Chi ZH; Zhang P
    Biol Trace Elem Res; 2016 Oct; 173(2):372-83. PubMed ID: 26956696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury.
    Liu W; Zhang X; Liu P; Shen X; Lan T; Li W; Jiang Q; Xie X; Huang H
    Eur J Pharmacol; 2010 Jul; 638(1-3):150-5. PubMed ID: 20447389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition.
    Kang MK; Park SH; Choi YJ; Shin D; Kang YH
    J Mol Med (Berl); 2015 Jul; 93(7):759-72. PubMed ID: 26062793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fraxin represses NF-κB pathway via inhibiting the activation of epidermal growth factor receptor to ameliorate diabetic renal tubulointerstitial fibrosis.
    Zeng J; Liang L; Chen R; Li C; Pan L; Wen M; Lv D; Liu M; Xu Z; Huang H
    Eur J Pharmacol; 2023 Sep; 955():175915. PubMed ID: 37467841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy.
    Lu Q; Ji XJ; Zhou YX; Yao XQ; Liu YQ; Zhang F; Yin XX
    Pharmacol Res; 2015 Sep; 99():237-47. PubMed ID: 26151815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of TSC1 promotes epithelial-mesenchymal transition of renal tubular epithelial cells in mouse diabetic nephropathy.
    Lu Q; Chen YB; Yang H; Wang WW; Li CC; Wang L; Wang J; Du L; Yin XX
    Acta Pharmacol Sin; 2019 Dec; 40(12):1555-1567. PubMed ID: 31235817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice.
    Yang G; Zhao Z; Zhang X; Wu A; Huang Y; Miao Y; Yang M
    Drug Des Devel Ther; 2017; 11():1065-1079. PubMed ID: 28408805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
    Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
    Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epiberberine ameliorated diabetic nephropathy by inactivating the angiotensinogen (Agt) to repress TGFβ/Smad2 pathway.
    Xiao Y; Deng J; Li C; Gong X; Gui Z; Huang J; Zhang Y; Liu Y; Ye X; Li X
    Phytomedicine; 2021 Mar; 83():153488. PubMed ID: 33571918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT.
    Lin S; Yu L; Ni Y; He L; Weng X; Lu X; Zhang C
    Diabetes Metab J; 2020 Feb; 44(1):158-172. PubMed ID: 31701691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
    Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
    Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
    Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
    Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting mammalian serine/threonine-protein kinase 4 through Yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis.
    Yang T; Heng C; Zhou Y; Hu Y; Chen S; Wang H; Yang H; Jiang Z; Qian S; Wang Y; Wang J; Zhu X; Du L; Yin X; Lu Q
    Metabolism; 2020 Jul; 108():154258. PubMed ID: 32376130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of S100A8/A9 ameliorates renal interstitial fibrosis in diabetic nephropathy.
    Du L; Chen Y; Shi J; Yu X; Zhou J; Wang X; Xu L; Liu J; Gao J; Gu X; Wang T; Yin Z; Li C; Yan M; Wang J; Yin X; Lu Q
    Metabolism; 2023 Jul; 144():155376. PubMed ID: 36521551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirt1 inhibits renal tubular cell epithelial-mesenchymal transition through YY1 deacetylation in diabetic nephropathy.
    Du L; Qian X; Li Y; Li XZ; He LL; Xu L; Liu YQ; Li CC; Ma P; Shu FL; Lu Q; Yin XX
    Acta Pharmacol Sin; 2021 Feb; 42(2):242-251. PubMed ID: 32555442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapeseed protein-derived antioxidant peptide RAP alleviates renal fibrosis through MAPK/NF-κB signaling pathways in diabetic nephropathy.
    Zhang M; Yan Z; Bu L; An C; Wang D; Liu X; Zhang J; Yang W; Deng B; Xie J; Zhang B
    Drug Des Devel Ther; 2018; 12():1255-1268. PubMed ID: 29795979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin attenuates renal tubulointerstitial fibrosis via upgrading autophagy in the early stage of diabetic nephropathy.
    Wang F; Sun H; Zuo B; Shi K; Zhang X; Zhang C; Sun D
    Sci Rep; 2021 Aug; 11(1):16362. PubMed ID: 34381133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.